1-12 of 12
Scott Kolodny
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Analysis of Durability of Response to Avatrombopag (AVA) from a Phase 3b Multicenter, Randomized, Double-Blind, Placebo (PBO)-Controlled, Parallel-Group Trial to Evaluate the Efficacy and Safety of AVA for the Treatment of Pediatric Patients with Immune Thrombocytopenia

Rachael F. Grace, Goksel Leblebisatan, Yesim Aydinok, Sule Unal, John D. Grainger, Jessica Zhang, Brian Jamieson, Scott Kolodny
Journal: Blood
Blood (2024) 144 (Supplement 1): 1191.
https://doi.org/10.1182/blood-2024-205431
Published: 2024
Journal Articles

Results of a Prospective, Open-Label, Phase 4 Study Evaluating the Safety, Efficacy, and Treatment Satisfaction in Adult Immune Thrombocytopenia (ITP) Subjects after Switching to Avatrombopag from Eltrombopag or Romiplostim

Michael D Tarantino, Scott Kolodny, Jessica Zhang, Brian Jamieson, Michael Vredenburg
Journal: Blood
Blood (2024) 144 (Supplement 1): 2560.
https://doi.org/10.1182/blood-2024-205489
Published: 2024
Journal Articles

Enhanced Patient Satisfaction and Stability of Platelet Counts Following a Switch from Eltrombopag (ELT) or Romiplostim (ROMI) to Avatrombopag (AVA) in Adult Idiopathic Thrombocytopenic Purpura (ITP): Post-Hoc Analyses from a Prospective Phase 4 Study

Michael D Tarantino, Scott Kolodny, Michael Marrone, Brian Jamieson, Michael Vredenburg
Journal: Blood
Blood (2024) 144 (Supplement 1): 2559.
https://doi.org/10.1182/blood-2024-205466
Published: 2024
Journal Articles

Real-World Treatment Patterns and Outcomes in Patients with Primary Immune Thrombocytopenia Treated with Avatrombopag in the United States: Real-AVA 2.0 Interim Analysis Results

Srikanth Nagalla, Moshe Y. Levy, Shruti Chaturvedi, Scott Kolodny, Abiola Oladapo, Chelsea Bernheisel, Elyse Swallow, Debbie Goldschmidt, Ali Greatsinger, Kirthana Sarathy, Loren Ormenaj, Michael Vredenburg
Journal: Blood
Blood (2024) 144 (Supplement 1): 3700.
https://doi.org/10.1182/blood-2024-200320
Published: 2024
Journal Articles

Interim Analysis of Platelet Response in a Prospective Phase 4 Study in Adult Immune Thrombocytopenia (ITP) Subjects after Switching from Eltrombopag (ELT) or Romiplostim (ROMI) to Avatrombopag (AVA)

Michael D. Tarantino, Scott Kolodny, Jessica Zhang, Brian Jamieson, Michael Vredenburg
Journal: Blood
Blood (2023) 142 (Supplement 1): 2577.
https://doi.org/10.1182/blood-2023-189908
Published: 2023
Journal Articles

Real-World Treatment Patterns and Outcomes in Patients with Immune Thrombocytopenia Treated with Avatrombopag in the United States: Real-AVA 2.0 Study Design

Srikanth Nagalla, Shruti Chaturvedi, Moshe Levy, Scott Kolodny, Abiola Oladapo, Chelsea Bernheisel, Brian Jamieson, Debbie Goldschmidt, Elyse Swallow, Ali Greatsinger, Michael Vredenburg
Journal: Blood
Blood (2023) 142 (Supplement 1): 5127.
https://doi.org/10.1182/blood-2023-189009
Published: 2023
Journal Articles

Interim Analysis of Treatment Satisfaction from a Prospective Phase 4 Study in Adult Immune Thrombocytopenia (ITP) Subjects after Switching from Eltrombopag or Romiplostim to Avatrombopag

Michael D. Tarantino, Scott Kolodny, Jessica Zhang, Brian Jamieson, Michael Vredenburg
Journal: Blood
Blood (2023) 142 (Supplement 1): 3954.
https://doi.org/10.1182/blood-2023-189224
Published: 2023
Journal Articles

Real-World Demographic and Clinical Characteristics of Patients Initiating Avatrombopag in the US: The Real-AVA Study

Scott Kolodny, Abiola Oladapo, Michael Vredenburg, Brian Jamieson, Elyse Swallow, Debbie Goldschmidt, Miriam L. Zichlin, Priscilla Lopez, Mikhail Davidson, John Yee
Journal: Blood
Blood (2022) 140 (Supplement 1): 13150–13151.
https://doi.org/10.1182/blood-2022-169369
Published: 2022
Journal Articles

Comparative Length of Therapy and Persistence Among Thrombopoietin Receptor Agonists (TPO-RA) in Immune Thrombocytopenia (ITP): United States Healthcare Claims and Specialty Pharmacy Prescription Analyses

Scott Kolodny, Brian Jamieson, Thomas Darden
Journal: Blood
Blood (2022) 140 (Supplement 1): 8414–8415.
https://doi.org/10.1182/blood-2022-168901
Published: 2022
Journal Articles

Avatrombopag Treatment Response in Patients with Immune Thrombocytopenia: A Real-World Evidence Study

Abiola Oladapo, Scott Kolodny, Michael Vredenburg, Brian Jamieson, Elyse Swallow, Debbie Goldschmidt, Miriam L. Zichlin, Mikhail Davidson, Louise Yu, John Yee
Journal: Blood
Blood (2022) 140 (Supplement 1): 10889–10890.
https://doi.org/10.1182/blood-2022-169162
Published: 2022
Journal Articles

Durability of Platelet Response When Switching from Eltrombopag or Romiplostim to Avatrombopag in Immune Thrombocytopenia (ITP): A Multicenter Study

Hanny Al-Samkari, Debbie Jiang, Terry B. Gernsheimer, Howard A. Liebman, Susie Lee, Chelsea Bernheisel, Scott Kolodny, Matthew Wojdyla, Michael Vredenburg, Brian Jamieson, Adam Cuker
Journal: Blood
Blood (2021) 138 (Supplement 1): 1015.
https://doi.org/10.1182/blood-2021-151321
Published: 2021
Journal Articles

Further Characterization of Thromboembolic Events and Association with Platelet Count Occurring during the Avatrombopag Immune Thrombocytopenia (ITP) Clinical Development Program

Caroline I. Piatek, Brian Jamieson, Scott Kolodny
Journal: Blood
Blood (2021) 138 (Supplement 1): 2086.
https://doi.org/10.1182/blood-2021-150897
Published: 2021